Germany: Leaked Pricing Measures Could Have ‘Drastic’ Consequences For Orphans

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

'Dangerous’ new measures outlined in a leaked bill would be a disaster for orphan drugs and lead to companies opting out of the German market, says one industry executive.

Germany Money
Leaked measures could drastically impact orphan prices in Germany • Source: Shutterstock

‘Drastic’ new proposals to curb pharmaceutical spending in Germany have been outlined in a leaked bill. The most “dangerous” measure would see the results of benefit assessments more closely linked to pricing caps and could cause orphan drug manufacturers to opt out of the German market, warns Alexander Natz, secretary general of EUCOPE, the European trade body for small to medium-sized innovative companies working in the field of pharmaceuticals and medical technologies.

The draft bill also introduces a new €1bn ($1.02bn) solidarity fund that companies would have to pay into.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography